EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smo

脑电图

基本信息

项目摘要

DESCRIPTION (provided by applicant): The proposal is to identify brain, behavioral, and self-report predictors of progression to changes in smoking rate and nicotine dependence in 128 young light smokers (YLS) in a longitudinal design using a number of novel predictors, including individual differences (IDs) in EEG and reward sensitivity at baseline and in response to standardized and to self-selected acute nicotine doses (ANIC). The associations of a compelling genetic functional variant polymorphism, rs16969968, in the alpha5 nicotinic receptor subunit will also be related to smoking progression and ANIC responses. The predictors will be attentional, affective, and reward-related processes assessed with brain (electrocortical), behavioral, and self-report indices that are well validated as responsive to ANIC in nicotine-dependent (ND) smokers. Evidence indicates that initial responses to first smoking experience, progression from light to regular smoking, and progression to ND are influenced by both genetic and environmental factors. There is good reason to hypothesize that better characterization of IDs in the effects of ANIC on attention, mood, and brain reactivity in YLS will provide important insights into mechanisms that contribute to the reinforcement of smoking and smoking trajectories in YLS. Such information could lead to targeted pharmacotherapy and behavioral interventions for at-risk YLS. The following hypotheses would be tested in a population of YLS: 1) ANIC will increase attention performance, mood, and resistance distraction by emotionally negatively valent pictures and words and that these beneficial (reinforcing) effects will predict changes in smoking rate 3, 6, 12, and 18 months later, 2) Lower baseline attentional and emotional levels will predict greater increases in smoking at the follow-ups. 3) Electrocortical (EEG, ERP, and source localization analyses) indices of low EEG activity (high theta & alpha power), reduced P3b amplitude, and greater reductions in P3b to targets following negatively valent distractor will predict increased smoking during nicotine deprived states and 4) hypotheses 1-3 will be supported even after controlling for social factors that may promote change in smoking. Secondary exploratory analyses will include the relationships of the functional variant polymorphism rs16969968 of the alpha5-alpha3-beta4 nicotinic receptor gene cluster to changes in smoking and to other predictors of change, including responses to ANIC.
描述(由申请人提供):该建议是为了在纵向设计中识别128名年轻吸烟者(YLS)中吸烟率和尼古丁依赖性变化的大脑,行为和自我报告预测因素,并使用许多新颖的预测因子(包括EEG中的个体差异(ID),包括在基线和对基线和对分配的NIC的响应中的敏感性(IDS)(IDS)。在alpha5烟碱受体亚基中,引人入胜的遗传功能变体多态性(RS16969968)的关联也将与吸烟进展和阳离子反应有关。这些预测因素将是通过大脑(电真),行为和自我报告指数评估的注意力,情感和奖励相关的过程,这些过程在尼古丁依赖性(ND)吸烟者中得到了很好的验证。证据表明,对初次吸烟经验的最初反应,从光到常规吸烟的发展以及ND的发展受遗传和环境因素的影响。有充分的理由假设在anic对YLS注意力,情绪和大脑反应性的影响中,更好地表征ID会为有助于加强YLS吸烟和吸烟轨迹的机制提供重要的见解。此类信息可能会导致有针对性的药物治疗和高危YLS的行为干预措施。以下假设将在YLS人群中进行检验:1)Anic会通过情绪上的情感情感图片和单词来增加注意力表现,情绪和抵抗力的注意力,并且这些有益的(增强)效应将预测吸烟率3、6、6、12和18个月后的变化将在随访中的吸烟中降低基线的注意力和降低基线的注意力和较低的情绪水平。 3) Electrocortical (EEG, ERP, and source localization analyses) indices of low EEG activity (high theta & alpha power), reduced P3b amplitude, and greater reductions in P3b to targets following negatively valent distractor will predict increased smoking during nicotine deprived states and 4) hypotheses 1-3 will be supported even after controlling for social factors that may promote change in smoking.次级探索性分析将包括alpha5-Alpha3-Beta4烟碱受体基因簇的功能变异多态性rs16969968与吸烟和其他变化预测指标的关系,包括对ANIC的反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID G GILBERT其他文献

DAVID G GILBERT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID G GILBERT', 18)}}的其他基金

Withdrawal Trajectory Predictors of Smoking Relapse
戒烟轨迹预测复吸的因素
  • 批准号:
    10303726
  • 财政年份:
    2021
  • 资助金额:
    $ 43.67万
  • 项目类别:
EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smo
脑电图
  • 批准号:
    8573522
  • 财政年份:
    2013
  • 资助金额:
    $ 43.67万
  • 项目类别:
EEG & Behavioral Predictors of Changes in Smoking Trajectories in Young Light Smo
脑电图
  • 批准号:
    8730593
  • 财政年份:
    2013
  • 资助金额:
    $ 43.67万
  • 项目类别:
Nicotine for Marijuana Withdrawal
尼古丁用于大麻戒断
  • 批准号:
    8146153
  • 财政年份:
    2010
  • 资助金额:
    $ 43.67万
  • 项目类别:
Nicotine for Marijuana Withdrawal
尼古丁用于大麻戒断
  • 批准号:
    8307865
  • 财政年份:
    2010
  • 资助金额:
    $ 43.67万
  • 项目类别:
Attentional Bias & Affect in Stress-Vulnerable Smokers
注意偏差
  • 批准号:
    6895583
  • 财政年份:
    2004
  • 资助金额:
    $ 43.67万
  • 项目类别:
Attentional Bias & Affect in Stress-Vulnerable Smokers
注意偏差
  • 批准号:
    7100953
  • 财政年份:
    2004
  • 资助金额:
    $ 43.67万
  • 项目类别:
Attentional Bias & Affect in Stress-Vulnerable Smokers
注意偏差
  • 批准号:
    7236178
  • 财政年份:
    2004
  • 资助金额:
    $ 43.67万
  • 项目类别:
Attentional Bias & Affect in Stress-Vulnerable Smokers
注意偏差
  • 批准号:
    6767208
  • 财政年份:
    2004
  • 资助金额:
    $ 43.67万
  • 项目类别:
Nicotine: Cognition-Affect Interactions
尼古丁:认知影响相互作用
  • 批准号:
    6881604
  • 财政年份:
    2003
  • 资助金额:
    $ 43.67万
  • 项目类别:

相似国自然基金

阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
  • 批准号:
    82302281
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
  • 批准号:
    22304039
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
  • 批准号:
    82300173
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
  • 批准号:
    82360957
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
  • 批准号:
    10701309
  • 财政年份:
    2023
  • 资助金额:
    $ 43.67万
  • 项目类别:
Circuit control of motivation to take and seek alcohol
饮酒和寻求酒精动机的电路控制
  • 批准号:
    10753712
  • 财政年份:
    2023
  • 资助金额:
    $ 43.67万
  • 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
  • 批准号:
    10736443
  • 财政年份:
    2023
  • 资助金额:
    $ 43.67万
  • 项目类别:
Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation
产前阿片类药物对大脑奖赏信号和新生儿喂养调节的性别特异性影响
  • 批准号:
    10506345
  • 财政年份:
    2023
  • 资助金额:
    $ 43.67万
  • 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
  • 批准号:
    10680616
  • 财政年份:
    2023
  • 资助金额:
    $ 43.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了